Seguici su acebook facebook Cerca nel sito:

Le ricerche di Gerona 2005

(21-10-15) Associations of advanced glycation endproducts with cognitive functions in individuals with and without type 2 diabetes.


Spauwen PJ1, van Eupen MG, Köhler S, Stehouwer CD, Verhey FR, van der Kallen CJ, Sep SJ, Koster A, Schaper NC, Dagnelie PC,Schalkwijk CG, Schram MT, van Boxtel MP.
Author information
Abstract
Context: Advanced glycation endproducts (AGEs) are thought to be involved in the pathogenesis of Alzheimer's disease. AGEs are products resulting from non-enzymatic chemical reactions between reduced sugars and proteins, which accumulate during natural aging and their accumulation is accelerated in hyperglycemic conditions such as type 2 diabetes mellitus. Objective: Examine associations between AGEs and cognitive functions Design, setting, participants: This study was performed as part of The Maastricht study, a population-based cohort study, in which, by design, 215 participants (28.1%) had type 2 diabetes mellitus. Main outcome measures: We examined associations of skin autofluorescence (SAF) (N=764), an overall estimate of skin AGEs, and specific plasma protein-bound AGEs (N=781) with performance on tests for global cognitive functioning, information processing speed, verbal memory (immediate and delayed word recall), and response inhibition. Results: After adjustment for demographics, diabetes, smoking, alcohol, waist circumference, total cholesterol/HDL cholesterol ratio, triglycerides, and lipid-lowering medication use, higher SAF was significantly associated with worse delayed word recall (regression coefficient b=-0.44, P=0.04), and response inhibition (b=0.03, P=0.04). After further adjustment for systolic blood pressure, cardiovascular disease, estimated glomerular filtration rate, and depression, associations were attenuated (delayed word recall: b=-0.38, P=0.07; response inhibition: b=0.02, P=0.07). Higher pentosidine levels were associated with worse global cognitive functioning (b=-0.61, P=0.04) after full adjustment, but other plasma AGEs were not. Associations did not differ between individuals with and without diabetes. Conclusion: We found inverse associations of SAF, a non-invasive marker for tissue AGES, with cognitive performance, which were attenuated after adjustment for vascular risk factors and depression.


Source: J Clin Endocrinol Metab. 2014 Dec 2:jc20142754. [Epub ahead of print]

News

  • (30-08-2018) The electronics in fluorescent bulbs and light emitting diodes (LED), rather than ultraviolet radiation, cause increased malignant melanoma incidence in indoor office workers and tanning bed users

    Leggi tutto

  • (30-08-2018) Mitocondri e peso forma

    Leggi tutto

  • (29-08-2018) Stroke now impacting younger patients as a result of the obesity epidemic; 4 in 10 are now aged 40-69

    Leggi tutto

  • (29-08-2018) Perdere peso non vuol dire perdere osso!

    Leggi tutto

  • (29-08-2018) Brain cholesterol: long secret life behind a barrier.

    Leggi tutto

  • (29-08-2018) Stile di vita sano? Si può, basta usare la fantasia

    Leggi tutto

  • (22-08-2018) Top 10 medical treatments that can make you SICKER than before you took them

    Leggi tutto

  • (22-08-2018) Meno ansia - C’è una associazione tra dieta e disturbi mentali?

    Leggi tutto

  • (22-08-2018) Dietary curcumin supplementation attenuates inflammation, hepatic injury and oxidative damage in a rat model of intra-uterine growth retardation.

    Leggi tutto

  • (22-08-2018) Dopo la gravidanza - Una dieta a basso indice glicemico se serve perdere peso

    Leggi tutto

  • (21-08-2018) Sleep Disturbances Can Be Prospectively Observed in Patients with an Inactive Inflammatory Bowel Disease.

    Leggi tutto

  • (21-08-2018) Anche i neo-papà soffrono della depressione post partum

    Leggi tutto


In evidenza

"L'informazione presente nel sito serve a migliorare, e non a sostituire, il rapporto medico-paziente."

Per coloro che hanno problemi di salute si consiglia di consultare sempre il proprio medico curante.

Informazioni utili